The Asia Pacific Endovascular Aneurysm Repair Market is expected to witness market growth of 5.6% CAGR during the forecast period (2022-2028).
Endovascular aneurysm repair surgery is said to be a minimally invasive approach operation that can be conducted in an outpatient clinic or an ASC. Endovascular aneurysms develop when the arterial wall becomes compromised. Atherosclerosis, trauma, or infection can cause the wall to weaken or be injured. Other common causes of the same in old age include hereditary disorders. Thoracic aortic aneurysms cause a weakening in the blood vessels that supply the body with oxygen and nutrients. An aneurysm occurs when the vessel wall bulges like a balloon as a result of severe pressure.
The stent graft is removed from the catheter after it is put into an artery in the upper thigh and threaded to the abdominal aorta, allowing blood to flow through the aneurysm. Recently, clinical trials of non-invasive therapy of abdominal aortic aneurysms on the growing largest transverse diameter of doxycycline have been conducted at Stanford Healthcare.
There is an increase in the investment by the governments of the region on strengthening the regional healthcare system. It's because of recent developments in medical science, as well as the governing focus of regions like Korea and Japan, to oppose and quickly improve and produce new items within the EVAR spectrum. In addition, disease-causing factors like diabetes are on the rise. In India, for example, 77 million persons have diabetes mellitus, which is one of the most common causes of aneurysms. However, due to improvements in healthcare facilities, abundant disposable income, and rapid economic development, Asia-Pacific is likely to emerge as a lucrative region with the greatest growth potential.
The China market dominated the Asia Pacific Endovascular Aneurysm Repair Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $278.5 million by 2028. The Japan market is estimated to grow at a CAGR of 5% during (2022-2028). Additionally, The India market is expected to display a CAGR of 6.3% during (2022-2028).
Based on Indication, the market is segmented into Abdominal and Thoratic. Based on Product, the market is segmented into Percutaneous Evar, Fenestrated Evar, Aortic Stents & Taa Graft, and Others. Based on Site, the market is segmented into Infrarenal and Pararenal. Based on Anatomy, the market is segmented into Traditional and Complex. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Endologix LLC, Lombard Medical Limited, Cardinal Health, Inc., Becton, Dickinson and Company, Medtronic PLC, Cook Medical, Inc., Koninklijke Philips N.V., Terumo Corporation, Abbott Laboratories, and Artivion, Inc.
By Indication
By Country
Endovascular aneurysm repair surgery is said to be a minimally invasive approach operation that can be conducted in an outpatient clinic or an ASC. Endovascular aneurysms develop when the arterial wall becomes compromised. Atherosclerosis, trauma, or infection can cause the wall to weaken or be injured. Other common causes of the same in old age include hereditary disorders. Thoracic aortic aneurysms cause a weakening in the blood vessels that supply the body with oxygen and nutrients. An aneurysm occurs when the vessel wall bulges like a balloon as a result of severe pressure.
The stent graft is removed from the catheter after it is put into an artery in the upper thigh and threaded to the abdominal aorta, allowing blood to flow through the aneurysm. Recently, clinical trials of non-invasive therapy of abdominal aortic aneurysms on the growing largest transverse diameter of doxycycline have been conducted at Stanford Healthcare.
There is an increase in the investment by the governments of the region on strengthening the regional healthcare system. It's because of recent developments in medical science, as well as the governing focus of regions like Korea and Japan, to oppose and quickly improve and produce new items within the EVAR spectrum. In addition, disease-causing factors like diabetes are on the rise. In India, for example, 77 million persons have diabetes mellitus, which is one of the most common causes of aneurysms. However, due to improvements in healthcare facilities, abundant disposable income, and rapid economic development, Asia-Pacific is likely to emerge as a lucrative region with the greatest growth potential.
The China market dominated the Asia Pacific Endovascular Aneurysm Repair Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $278.5 million by 2028. The Japan market is estimated to grow at a CAGR of 5% during (2022-2028). Additionally, The India market is expected to display a CAGR of 6.3% during (2022-2028).
Based on Indication, the market is segmented into Abdominal and Thoratic. Based on Product, the market is segmented into Percutaneous Evar, Fenestrated Evar, Aortic Stents & Taa Graft, and Others. Based on Site, the market is segmented into Infrarenal and Pararenal. Based on Anatomy, the market is segmented into Traditional and Complex. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Endologix LLC, Lombard Medical Limited, Cardinal Health, Inc., Becton, Dickinson and Company, Medtronic PLC, Cook Medical, Inc., Koninklijke Philips N.V., Terumo Corporation, Abbott Laboratories, and Artivion, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Indication
- Abdominal
- Thoratic
- Percutaneous Evar
- Fenestrated Evar
- Aortic Stents & Taa Graft
- Others
- Infrarenal
- Pararenal
- Traditional
- Complex
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Endologix LLC
- Lombard Medical Limited
- Cardinal Health, Inc.
- Becton, Dickinson and Company
- Medtronic PLC
- Cook Medical, Inc.
- Koninklijke Philips N.V.
- Terumo Corporation
- Abbott Laboratories
- Artivion, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. Asia Pacific Endovascular Aneurysm Repair Market by Indication
Chapter 5. Asia Pacific Endovascular Aneurysm Repair Market by Product
Chapter 6. Asia Pacific Endovascular Aneurysm Repair Market by Site
Chapter 7. Asia Pacific Endovascular Aneurysm Repair Market by Anatomy
Chapter 8. Asia Pacific Endovascular Aneurysm Repair Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Endologix LLC
- Lombard Medical Limited
- Cardinal Health, Inc.
- Becton, Dickinson and Company
- Medtronic PLC
- Cook Medical, Inc.
- Koninklijke Philips N.V.
- Terumo Corporation
- Abbott Laboratories
- Artivion, Inc.
Methodology
LOADING...
